Heat shock protein 72 suppresses apoptosis by increasing the stability of X-linked inhibitor of apoptosis protein in renal ischemia/reperfusion injury
- Authors:
- Published online on: November 13, 2014 https://doi.org/10.3892/mmr.2014.2939
- Pages: 1793-1799
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
Abstract
Introduction
Apoptosis is the major pathogenetic mechanism of early tubular cell death in ischemia/reperfusion (I/R)-induced acute kidney injury (AKI). Under I/R conditions, disruption of the outer mitochondrial membrane potential and permeability, leading to the release of multiple toxic proteins, has been implicated in activating apoptotic signaling (1,2). However, the cell death pathway exists in a state of dynamic equilibrium between pro and anti-apoptotic effector molecules. The inhibitor of apoptosis proteins (IAP), for example, negatively regulate apoptotic signaling at a post-mitochondrial level. Among the IAP family, X-linked inhibitor of apoptosis protein (XIAP) appears to be the most potent caspase inhibitor by directly binding and inhibiting caspase targets, including caspase-3, 7 and 9. In addition, in response to apoptotic stimuli, the inhibitory function of XIAP can be antagonized by second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low PI (DIABLO) (3–7), which is also released from mitochondria as cytochrome c. In addition, interaction of XIAP with Smac/DIABLO has been demonstrated to mediate apoptosis following diverse insults, including ischemia (8–10), oxidative stress (11) and ultraviolet radiation (12,13). Despite these findings, the role of Smac/DIABLO and XIAP in renal I/R remains to be elucidated.
Heat shock protein 72 (HSP72), a major stress inducible protein, functions as a molecular chaperone in protein folding, transport and degradation. Previous studies from our laboratory (Renal Section, Department of Medicine, Boston Medical Center, Boston University, Boston, MA, USA) and elsewhere have revealed that HSP72 protects renal epithelial cells from apoptosis by reducing mitochondrial membrane injury and inhibiting mitochondrial release of cytochrome c and apoptosis-inducing factor (AIF) (7,14,15). Furthermore, this evidence also suggests that HSP72 attenuates renal fibrosis through inhibiting epithelial-to-mesenchymal transition (16,17). Thus, induction of HSP72 may have wide-ranging effects in the treatment of acute and chronic renal injury. However, it remains to be elucidated whether HSP72 protects against I/R-induced renal tubular cell injury through modulation of Smac/DIABLO and XIAP signaling.
In the present study, it was hypothesized that HSP72 reduces mitochondrial Smac/DIABLO release, prevents XIAP degradation and thereby promotes tubular cell survival in renal I/R injury.
Materials and methods
Reagents and antibodies
Geranylgeranylacetone (GGA) was obtained from Eisai China (Shanghai, China). Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay kits (fluorescent), annexin V fluorescein isothiocyanate apoptosis detection kits and protease inhibitors were obtained from Calbiochem (San Diego, CA, USA). In addition, the following antibodies were used: mouse anti-human HSP72 (1:1,000; Stressgen Biotechnologies, Victoria, BC, Canada), rabbit anti-human XIAP (1:1,000; BD Biosciences, San Jose, CA, USA), mouse anti-human Smac/DIABLO (1:1,000; BD Biosciences), rabbit anti human pro caspase 3 (1:500; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and mouse anti-human β-actin (1:2,000; Boster, Wuhan, China). Horseradish peroxidase-conjugated anti-mouse IgG and horseradish peroxidase conjugated anti-rabbit IgG were obtained from Jackson ImmunoResearch (West Grove, PA, USA). All remaining reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Cell culture and treatment
An immortalized proximal tubule epithelial cell line from normal adult human kidney (HK-2) was purchased from the American Type Culture Collection (Rockville, MD, USA). Cells were cultured at 37°C in a 5% carbon dioxide atmosphere in Dulbecco’s modified Eagle’s medium mixed 1:1 (vol:vol) with F12 medium (Invitrogen Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum. Cells were grown to 70–80% confluence and subjected to serum-deprivation for 24 h prior to experimental manipulation.
Induction of HSP72
HSP72 protein content was enhanced by coinfecting HK-2 cells with adenoviruses containing wild-type human HSP72 and green fluorescent protein (AdvTR5/HSP72-GFP) located on separate cistrons induced by a tetracyclin-regulated promoter (AdvCMV/tTA) as described previously (16). To induce optimal renal HSP72 expression, GGA was emulsified with 5% gum arabic and 0.008% tocopherol and administered to rats as previously described (16). Briefly, rats received daily oral administration with 400 mg/kg GGA, starting one day prior to surgery and continuing throughout I/R or sham surgery. Control animals were administered the same volume of components without GGA (vehicle).
Animals
The experiments were performed with adult male Sprague-Dawley rats weighing 200–250 g maintained with free access to water and standard food. Renal I/R studies were performed using the protocol approved by the Animal Care and Use Committee of the Sun Yat-sen University (Guangzhou, China). Rats were randomly allocated into three groups: i) Sham-surgery controls receiving vehicle (n=8); ii) I/R group receiving vehicle (n=8); iii) I/R group receiving GGA (n=8).
Renal I/R injury was induced as previously described (18). Briefly, rats were anesthetized by an intraperitoneal injection of chloral hydrate (350 mg/kg) and placed on a sterile disposable towel over a warming pad. A midline incision was made and the renal pedicles were bluntly dissected. The left renal pedicles were occluded with a nontraumatic vascular clamp for 45 min and subsequently allowed to reperfuse following removal of the clamp. The right kidney was removed. The incision was closed with 3-0 silk and rats were returned to cages to recover. The rats in the sham-surgery group were treated in an identical manner, with the exception of clamping of the renal pedicles. Animals were sacrificed following 24 h of reperfusion. Subsequently, blood samples were collected by heart puncture for measurement of creatinine and urea nitrogen and the left kidney was harvested and subjected to further investigation as described below.
Renal function examination
Blood urea nitrogen (BUN) and creatinine levels were measured using a QuantiChrom BUN or Creatinine assay kit (BioAssay Systems, Hayward, CA, USA).
Histological analysis and apoptosis assay
Kidney tissues were fixed in 10% phosphate-buffered formalin, embedded in paraffin, sectioned at 3 μm thickness and then stained with hematoxylin and eosin or periodic acid-Schiff (PAS). Histological examinations were performed in a blinded manner and scores were calculated on the basis of the percentage of damaged tubules in 20 randomly selected cortical tubules with visible basement membranes at ×400 magnification (Axioplan 2 imaging; Carl Zeiss, Oberkochen, Germany). A five-point scale was used: 0, Normal; 1, <10%; 2, 11–25%; 3, 25–50%; 4, 51–75% and 5, >75%.
Apoptosis was quantified in histological sections using a commercially available TACS TdT-Fluor In Situ Apoptosis Detection kit (R&D Systems, Inc., Minneapolis, MN, USA) according to the manufacturer’s instructions and our previous study (16). Briefly, paraffin-embedded kidney sections were deparaffinized, permeabilized and rehydrated. Slides were incubated with a TUNEL reaction mixture containing terminal deoxynucleotidyl transferase. Positive staining was identified in the cell nucleus with DNA fragmentation under confocal microscopy (Zeiss LSM 510 META; Carl Zeiss) microscopy and expressed as apoptotic cells per high-power field.
Western blot analysis
Kidney cortex and harvested cultured cells were homogenized in lysis buffer supplemented with a protease inhibitor cocktail (Cell Signaling Technology, Inc., Beverly, MA, USA). Cytosolic protein fractions were obtained through incubation of cells with digitonin buffer [10 mM piperazine-N,N′-bis(2-ethanesulfonic acid), pH 6.8, 0.015% (wt/vol) digitonin, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, 5 mM EDTA and 1 mM phenylmethylsulfonyl fluoride] for 10 min at 4°C (7). The supernatants of tissue, cell lysates and cytosolic protein extracts were extracted, subjected to protein assay and mixed with sodium dodecyl sulfate (SDS) loading buffer. Samples were loaded and separated by 12% SDS polyacrylamide gels (SDS-PAGE), electrotransferred onto a nitrocellulose membrane, blotted with the designated antibodies and then detected by enhanced chemiluminescence (Amersham Pharmacia Biotech, Amersham, UK). Densitometric quantification was performed with the image analysis program (Fluorchem™ 8900; Alpha Innotech, San Leandro, CA, USA).
Immunoprecipitation analysis
Cytosolic protein fractions were dissolved in immunoprecipitation buffer (0.5–1 mg of protein/ml) as described previously (17). The cell lysates were incubated overnight at 4°C with a polyclonal rabbit antibody directed against human XIAP (2 μg/mg protein/ml immunoprecipitation buffer; BD Biosciences). The immunocomplexes were isolated by incubation at 4°C with Protein A/G PLUS agarose beads (Pierce Biotechnology Inc., Rockford, IL, USA) for 2 h, washed three times with the immunoprecipitation buffer and analyzed using the indicated antibody by SDS-PAGE and western blotting.
Statistical analysis
All results are expressed as the mean ± standard error of the mean. Analysis was performed with standard statistical software (SPSS 11.0; SPSS, Inc., Chicago, IL, USA). Comparison among groups was performed using a one-way analysis of variance followed by the Student-Newman-Keuls test. P<0.05 was considered to indicate a statistically significant difference.
Results
GGA attenuates I/R-induced renal injury
Previous studies from our laboratory and others have demonstrated that orally administered GGA selectively enhances expression of HSP72 in the kidney (16,19). In order to assess the protective roles of GGA in acute kidney injury, renal function was evaluated in a rat I/R injury model. Compared with the sham-surgery group, the I/R rats with vehicle alone exhibited marked and progressive elevation in the levels of BUN and creatinine. By contrast, GGA administration significantly improved renal dysfunction 24 h after reperfusion (Fig. 1A and B). Concordantly, histological analysis of PAS staining revealed that I/R in the vehicle group caused significant brush border loss, detached tubular epithelium, cast formation and tubular dilation compared with the sham-surgery group. However, GGA treatment exhibited significant improvements in renal morphology (Fig. 1C) and reduced the tubular injury score (Fig. 1D). Of note, GGA did not alter renal function and morphology in rats subjected to sham I/R.
GGA inhibits apoptosis and XIAP degradation
To examine the potential mechanism for the renal protective effect of GGA, the apoptosis of tubular cells was detected using TUNEL staining. As shown in Fig. 2A, renal TUNEL-positive cells, predominantly located at the proximal tubules, were increased in vehicle-treated I/R kidneys, as compared with those of the sham-surgery group. A significantly lower number of apoptotic cells were observed in the GGA-treated kidneys subjected to I/R (Fig. 2A and B).
XIAP has been observed to suppress cell death by directly inhibiting caspase activity (20). Therefore, the impact of GGA on the steady-state levels of XIAP were examined. As shown in Fig. 2C and D, XIAP protein levels in the kidney were significantly reduced following I/R injury in the vehicle-treated rats, which was consistent with increased apoptosis. The administration of GGA markedly enhanced HSP72 expression, corresponding with preservation of XIAP protein contents. These findings suggest that HSP72 may protect the kidney against I/R-induced injury, at least in part, through inhibiting XIAP degradation.
HSP72 prevents Smac/DIABLO release and caspase 3 activation
In response to apoptotic stimuli, Smac/DIABLO protein is redistributed from the mitochondria to the cytosol, binds to XIAP and activates the apoptosome complex. As GGA exposure preserved XIAP protein levels, attenuated apoptosis and protected against I/R renal injury in rats, the function of HSP72 in regulating mitochondrial Smac/DIABLO translocation and caspase 3 activation were examined in cultured epithelial tubular cells subjected to ATP depletion, as previously described (7). Under normal conditions, Smac/DIABLO was not detected in the cytosol of empty vector cells. ATP depletion caused a marked increase in cytosolic Smac/DIABLO. The quantity of Smac/DIABLO progressively enhanced during recovery from transient ATP depletion. However, HSP72 overexpression significantly inhibited mitochondrial Smac/DIABLO release (Fig. 3A and B). Concordantly, levels of pro-caspase 3 were reduced in metabolic inhibitor-treated control cells, whereas caspase 3 activation was efficiently inhibited in HSP72 overexpressing cells (Fig. 3C and D). Without metabolic inhibitor exposure, HSP72 overexpression per se did not affect Smac/DIABLO leakage and pro-caspase 3 content. This result suggested that HSP72 may confer protective effects in part by inhibiting mitochondrial Smac/DIABLO protein release.
HSP72 stabilizes XIAP protein
XIAP is degraded during apoptosis induction (21). Since HSP72 preserved XIAP protein content in rats subjected to renal I/R, whether XIAP degradation may be suppressed by HSP72 in HK-2 cells was further examined. Consistent with our in vivo findings, overexpression of HSP72 increased the stabilization of XIAP protein following ATP depletion, compared with that in the empty vector control cells (Fig. 4A and B). To examine the possibility that HSP72 may prevent XIAP degradation by binding to XIAP, immunoprecipitation of the two proteins was performed. In the empty vector control cells, interaction between HSP72 and XIAP was weak, whereas overexpression of HSP72 significantly elevated the interaction between these two proteins under all experimental conditions. The immunoprecipitable XIAP content was similar (Fig. 5). The present results suggest that HSP72 may confer XIAP stability against degradation through binding XIAP.
Discussion
The present study demonstrated that induction of HSP72 by GGA preserved renal XIAP protein content, attenuated tubular cell apoptosis and improved renal dysfunction following I/R injury. In vitro experiments in HK-2 cells revealed that overexpression of HSP72 inhibited mitochondrial Smac/DIABLO release, interacted with XIAP and increased levels of XIAP and pro-caspase 3 in ATP-depleted cells. These findings suggest that elevated expression of HSP72 prevents the onset of tubular cell apoptosis in renal I/R injury through suppression of Smac/DIABLO release from mitochondria and restoring XIAP and pro-caspase 3 protein level.
Transient ischemia due to hypovolemia, hypotension or heart failure commonly causes AKI, a disease associated with high mortality, which is increasing in prevalence. Experimental and human studies indicate that the mitochondrial-mediated apoptotic pathway contributes to tubular cell detachment, loss and dysfunction in the course of acute and chronic renal injury (8,22–25). The present study, as well as previous studies (22,24), demonstrated that tubular apoptosis was markedly increased in the I/R-subjected kidney compared with the sham-surgery-subjected kidney. Notable evidence indicates that an alteration in mitochondrial membrane integrity is crucial to the regulation of apoptosis, as stress-mediated permeabilization permits pro-apoptotic factors from the mitochondria into the cytosol and activates caspase-dependent and independent pathways (1,2). The present study demonstrated that mitochondrial Smac/DIABLO, like cytochrome c and AIF (7,15) rapidly release into the cytosol of renal tubular cells during exposure to metabolic inhibitors. During recovery from ATP depletion and following release of mitochondrial Smac/DIABLO, the protein levels of pro-caspase 3 and the caspase inhibitory function of XIAP were reduced. These findings are in agreement with those of previous studies and suggest that Smac/DIABLO from mitochondria ensures continued caspase activation, which is essential ultimately for cell death by inhibiting the caspase inhibitory function of IAPs (3,5,26)
HSP72 is an abundant, inducible molecular chaperone. Multiple studies have demonstrated that HSP72 may protect a variety of cells, including renal tubule cells, against thermal, toxic and ATP depletion-induced damage in vitro (7,15,27). Overexpression of HSP72 also suppresses I/R-mediated myocardial, liver, brain and renal injury in animals (28–30). Through release of mitochondrial Smac/DIABLO, it is hypothesized that HSP72 regulates Smac/DIABLO translocation and promotes cell survival during ischemic AKI. In our previous study, administered GGA specifically enhanced the expression of HSP72 in the kidney (16). The present data revealed that pre-conditioning rats with GGA attenuated tubular epithelial cell injury, apoptosis and renal dysfunction. The in vitro data substantiated the cytoprotective function of HSP72. As observed following ischemia in vivo, overexpressed HSP72 in cultured HK-2 cells attenuated mitochondrial Smac/DIABLO release into the cytosol, degradation of XIAP and the activation of caspase 3. Since HSP72 has been observed to bind to various signaling molecules, it may impact on cell survival. In the present study, the interaction between HSP72 and XIAP was increased under pathophysiological conditions and even elevated following overexpression of HSP72 in the cells. Smac/DIABLO was found to promote caspase activation by binding and neutralizing the IAPs, including XIAP (3). The present observations indicate that HSP72 functions as a regulator that prevents XIAP degradation upon apoptotic signaling, competitively inhibits the binding of XIAP and Smac/DIABLO and maintains the association of XIAP with caspase, thereby preventing apoptosis.
In conclusion, the present study has revealed that HSP72 prevents tubular apoptosis and dysfunction in renal I/R injury by suppressing the release of mitochondrial Smac/DIABLO and protecting the functions of pro-apoptotic proteins.
Acknowledgements
This study was supported by the National Natural Science Foundation of China (grant nos. 81070553, 81270783 and 81130012) and the National Basic Research Program of China (grant no. 2012CB517700-2012CB517706).
References
Suen DF, Norris KL and Youle RJ: Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590. 2008. View Article : Google Scholar : PubMed/NCBI | |
Brooks C, Wei Q, Cho SG and Dong Z: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 119:1275–1285. 2009. View Article : Google Scholar : PubMed/NCBI | |
Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:33–42. 2000. View Article : Google Scholar : PubMed/NCBI | |
Deveraux QL, Takahashi R, Salvesen GS and Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300–304. 1997. View Article : Google Scholar : PubMed/NCBI | |
Verhagen AM, Ekert PG, Pakusch M, et al: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 102:43–53. 2000. View Article : Google Scholar : PubMed/NCBI | |
Fulda S and Vucic D: Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov. 11:109–124. 2012. View Article : Google Scholar : PubMed/NCBI | |
Li F, Mao HP, Ruchalski KL, et al: Heat stress prevents mitochondrial injury in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol. 283:C917–C926. 2002. View Article : Google Scholar : PubMed/NCBI | |
Bonventre JV and Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 14:2199–2210. 2003. View Article : Google Scholar : PubMed/NCBI | |
Russell JC, Whiting H, Szuflita N and Hossain MA: Nuclear translocation of X-linked inhibitor of apoptosis (XIAP) determines cell fate after hypoxia ischemia in neonatal brain. J Neurochem. 106:1357–1370. 2008. View Article : Google Scholar : PubMed/NCBI | |
Scarabelli TM, Stephanou A, Pasini E, et al: Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol. 43:865–874. 2004. View Article : Google Scholar : PubMed/NCBI | |
Saito A, Hayashi T, Okuno S, Nishi T and Chan PH: Oxidative stress is associated with XIAP and Smac/DIABLO signaling pathways in mouse brains after transient focal cerebral ischemia. Stroke. 35:1443–1448. 2004. View Article : Google Scholar : PubMed/NCBI | |
de Almagro MC and Vucic D: The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol. 34:200–211. 2012.PubMed/NCBI | |
Hu W, Wang F, Tang J, et al: Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. J Biol Chem. 287:68–80. 2012. View Article : Google Scholar : | |
Mosser DD, Caron AW, Bourget L, Denis-Larose C and Massie B: Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 17:5317–5327. 1997.PubMed/NCBI | |
Ruchalski K, Mao H, Li Z, et al: Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J Biol Chem. 281:7873–7880. 2006. View Article : Google Scholar : PubMed/NCBI | |
Mao H, Li Z, Zhou Y, et al: HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol. 295:F202–F214. 2008. View Article : Google Scholar : PubMed/NCBI | |
Zhou Y, Mao H, Li S, et al: HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition. J Am Soc Nephrol. 21:598–609. 2010. View Article : Google Scholar : PubMed/NCBI | |
Wang Z, Gall JM, Bonegio RG, et al: Induction of heat shock protein 70 inhibits ischemic renal injury. Kidney Int. 79:861–870. 2011. View Article : Google Scholar : PubMed/NCBI | |
Suzuki S, Maruyama S, Sato W, Morita Y, Sato F, Miki Y, Kato S, Katsuno M, Sobue G, Yuzawa Y and Matsuo S: Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int. 67:2210–2220. 2005. View Article : Google Scholar : PubMed/NCBI | |
Eckelman BP, Salvesen GS and Scott FL: Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7:988–994. 2006. View Article : Google Scholar : PubMed/NCBI | |
Yang Y, Fang S, Jensen JP, Weissman AM and Ashwell JD: Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 288:874–877. 2000. View Article : Google Scholar : PubMed/NCBI | |
Havasi A and Borkan SC: Apoptosis and acute kidney injury. Kidney Int. 80:29–40. 2011. View Article : Google Scholar : PubMed/NCBI | |
Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F and Mayer G: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol. 10:2006–2013. 1999.PubMed/NCBI | |
Kaushal GP, Basnakian AG and Shah SV: Apoptotic pathways in ischemic acute renal failure. Kidney Int. 66:500–506. 2004. View Article : Google Scholar : PubMed/NCBI | |
Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J and Ortiz A: Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 19:1634–1642. 2008. View Article : Google Scholar : PubMed/NCBI | |
Song Z, Yao X and Wu M: Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem. 278:23130–23140. 2003. View Article : Google Scholar : PubMed/NCBI | |
Zhao S, Lin Q, Li H, et al: Carbon monoxide releasing molecule-2 attenuated ischemia/reperfusion induced apoptosis in cardiomyocytes via a mitochondrial pathway. Mol Med Rep. 9:754–762. 2014. | |
Pabla N, Dong G, Jiang M, et al: Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer. J Clin Invest. 121:2709–2722. 2011. View Article : Google Scholar : PubMed/NCBI | |
Tan Z, Turner RC, Leon RL, et al: Bryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic stroke. Stroke. 44:3490–3497. 2013. View Article : Google Scholar : PubMed/NCBI | |
Fang H, Liu A, Dahmen U and Dirsch O: Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. Cell Death Dis. 4:e6942013. View Article : Google Scholar : PubMed/NCBI |